Company intelligence / Profile preview

Pukang Biotechnology

Hangzhou, Zhejiang, China
Ownership
Private
Employees
~500
Development stage
Other
01

Overview

Zhejiang Pukang Biotechnology is a prominent Chinese biopharmaceutical company focused on the research, development, and manufacturing of human vaccines. Founded in 1987 by Academician Mao Jiangsen, the company is globally recognized for developing the H2-strain live attenuated Hepatitis A vaccine, which has significantly impacted public health in China and abroad. The company's portfolio includes commercialized vaccines for Hepatitis A and Varicella, produced in large-scale GMP-compliant facilities. Pukang Biotechnology serves as a key player in China's national immunization infrastructure and continues to innovate in the field of viral disease prevention.

Therapeutic areas
Infectious Diseases
Modalities
VaccineBiologic
Industry
Biotech
02

Drug pipeline

2 assets

human papillomavirus type 16 recombinant adenoviral vector vaccine

Unknown

1 more asset in the full pipeline.

Request access →
03

Partnerships

Institute of Medical Biology (IMBCAMS)World Health Organization (WHO)

Beyond the preview

Go deeper on Pukang Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pukang Biotechnology.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call